trihexyphenidyl has been researched along with Stroke in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Excerpt | Relevance | Reference |
|---|---|---|
| "These eye movement disorders can result in difficulty maintaining the normal ocular position and difficulty moving the eyes appropriately." | 2.47 | Interventions for disorders of eye movement in patients with stroke. ( Angilley, J; Dhillon, B; Hazelton, C; Henderson, CA; Langhorne, P; Livingstone, K; Munro, FA; Orr, H; Pollock, A; Rowe, FJ; Shahani, U, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pollock, A | 1 |
| Hazelton, C | 1 |
| Henderson, CA | 1 |
| Angilley, J | 1 |
| Dhillon, B | 1 |
| Langhorne, P | 1 |
| Livingstone, K | 1 |
| Munro, FA | 1 |
| Orr, H | 1 |
| Rowe, FJ | 1 |
| Shahani, U | 1 |
1 review available for trihexyphenidyl and Stroke
| Article | Year |
|---|---|
Interventions for disorders of eye movement in patients with stroke.
Topics: Activities of Daily Living; Adult; Humans; Muscarinic Antagonists; Ocular Motility Disorders; Random | 2011 |